摘要
非酒精性脂肪性肝病(NAFLD)是以肝脂肪变性为主要特征的一系列疾病谱的概括,是一种代谢相关性疾病,也是肝纤维化、肝硬化和肝癌的重要风险因子。内质网是调节脂代谢的核心场所,而非折叠蛋白反应是内质网应激(ERS)的重要过程。基于内质网在代谢相关疾病中的重要应激作用,本文将从ERS角度,探寻其与NAFLD之间的影响机制,对NAFLD病理发展过程中脂质代谢、炎症反应、细胞死亡、纤维化及ERS靶向治疗的相关研究进展进行综述。
Non-alcoholic fatty liver disease(NAFLD)is a series of diseases characterized by hepatic steatosis and is also a metabolism-associated disease and an important factor for liver fibrosis,liver cirrhosis,and hepatocellular carcinoma.Endoplasmic reticulum is a core organelle for the regulation of lipid metabolism,and unfolded protein response is an important process of endoplasmic reticulum stress(ERS).Based on the important stress role of endoplasmic reticulum in metabolism-associated diseases,this article explores the influencing mechanism between ERS and NAFLD and reviews the research advances in lipid metabolism,inflammatory response,hepatocyte death,fibrosis,and ERS-targeted therapies in the pathological development of NAFLD.
作者
李岫滟
雷娜
宋虹霏
曾玲
王东
穆杰
LI Xiuyan;LEI Na;SONG Hongfei;ZENG Ling;WANG Dong;MU Jie(School of Basic Medical Sciences,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,China;Chongqing Traditional Chinese Medicine Hospital,Chongqing 400021,China)
出处
《临床肝胆病杂志》
CAS
北大核心
2024年第11期2300-2305,共6页
Journal of Clinical Hepatology
基金
国家自然科学基金青年项目(82104655)
四川省自然科学基金面上项目(2024NSFSC0692)。
关键词
非酒精性脂肪性肝病
内质网应激
非折叠蛋白质应答
分子靶向治疗
Non-alcoholic Fatty Liver Disease
Endoplasmic Reticulum Stress
Unfolded Protein Response
Molecular Targeted Therapy